BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 25495971)

  • 1. Management of neonatal abstinence syndrome in the newborn nursery.
    Artigas V
    Nurs Womens Health; 2014 Dec; 18(6):509-14. PubMed ID: 25495971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mothers on methadone: care in the NICU.
    Maguire DJ
    Neonatal Netw; 2013; 32(6):409-15. PubMed ID: 24195801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal methadone treatment and neonatal abstinence syndrome.
    Liu WF; Singh K; Faisal M; Li S
    Am J Perinatol; 2015 Sep; 32(11):1078-86. PubMed ID: 25915141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal abstinence syndrome: therapeutic interventions.
    Sublett J
    MCN Am J Matern Child Nurs; 2013 Mar; 38(2):102-7; quiz 107-9. PubMed ID: 23187048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
    Bhatt-Mehta V; Ng CM; Schumacher RE
    Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
    Jones HE; Fielder A
    Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breastfeeding promotion for management of neonatal abstinence syndrome.
    Pritham UA
    J Obstet Gynecol Neonatal Nurs; 2013; 42(5):517-26. PubMed ID: 24020477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opioid-exposed newborn: assessment and pharmacologic management.
    Jansson LM; Velez M; Harrow C
    J Opioid Manag; 2009; 5(1):47-55. PubMed ID: 19344048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neonatal abstinence syndrome and maternal toxicological profile].
    Fundarò C; Solinas A; Martino AM; Genovese O; Noia G; Conte GL; Segni G
    Minerva Pediatr; 1994 Mar; 46(3):83-8. PubMed ID: 8035762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
    Mactier H; McLaughlin P; Gillis C; Osselton MD
    Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
    [No Abstract]   [Full Text] [Related]  

  • 16. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy and the Opioid Epidemic.
    Haycraft AL
    J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):19-23. PubMed ID: 29505087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal buprenorphine treatment and infant outcome.
    Jansson LM; Velez ML; McConnell K; Spencer N; Tuten M; Jones H; Rios R; King VL; Gandotra N; Millio L; DiPietro JA
    Drug Alcohol Depend; 2017 Nov; 180():56-61. PubMed ID: 28869859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.